Atara Biotherapeutics ATRA
NASDAQ ATRA
$8.46 -0.04 (-0.47%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) Depreciation & Amortization (CF) (2013 - 2026)

Updated

Atara Biotherapeutics (ATRA) posted Depreciation & Amortization (CF) of $14,000 for Q2 2026, down 94.1% from $236,000 a year earlier and down 51.7% from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Atara Biotherapeutics was $128,000, down 97.1% year-over-year; for FY2025, it came in at $2.12 million, down 58.1% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -24.0% (FY2020 to FY2025).
  • In prior years, Atara Biotherapeutics' Depreciation & Amortization (CF) was $5.05 million in FY2024 (+4.6%), $4.83 million in FY2023 (-14.6%), $5.65 million in FY2022 (-39.5%) and $9.35 million in FY2021 (+12.2%).
  • The Q2 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) since Q3 2015.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last five quarters, with an average decline of 55.7% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2025, with growth of 29.0%; the weakest was Q1 2026, with a decline of 98.4%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $29,000 (Q1 2026), $49,000 (Q4 2025) and $36,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Atara Biotherapeutics 127.78 Mn 117.88 Mn 439,000.00 14,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14,000.00
Mar 31, 2026 29,000.00
Dec 31, 2025 49,000.00
Sep 30, 2025 36,000.00
Jun 30, 2025 236,000.00
Mar 31, 2025 1.80 Mn
Dec 31, 2024 1.10 Mn
Sep 30, 2024 1.23 Mn
Jun 30, 2024 1.33 Mn
Mar 31, 2024 1.39 Mn
Dec 31, 2023 1.21 Mn
Sep 30, 2023 1.21 Mn
Jun 30, 2023 1.20 Mn
Mar 31, 2023 1.21 Mn
Dec 31, 2022 1.26 Mn
Sep 30, 2022 1.40 Mn
Jun 30, 2022 1.40 Mn
Mar 31, 2022 1.59 Mn
Dec 31, 2021 2.45 Mn
Sep 30, 2021 2.30 Mn
API Access

Atara Biotherapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ATRA&period=max&api_key=YOUR_API_KEY